Hipersensibilidad selectiva a inhibidores de la ciclooxigenasa-2
Introducción: Los inhibidores de la ciclooxigenasa-2 suelen indicarse en pacientes con hipersensibilidad múltiple a los antiinflamatorios no esteroides. Sin embargo, se han descrito reacciones de hipersensibilidad inmediata y retardada, además de posible reactividad cruzada con sulfonamidas. Repo...
Main Authors: | Laura Romero Sánchez, Sara López Freire, Paula Méndez Brea, Teresa González Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2023-01-01
|
Series: | Revista Alergia México |
Subjects: | |
Online Access: | https://revistaalergia.mx/ojs/index.php/ram/article/view/1026 |
Similar Items
-
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
by: Afaf A. El-Malah, et al.
Published: (2022-07-01) -
Defined Daily Dose and Appropriateness of Clinical Application: The Coxibs and Traditional Nonsteroidal Anti-Inflammatory Drugs for Postoperative Orthopaedics Pain Control in a Private Hospital in Malaysia
by: Faizah Safina Bakrin, et al.
Published: (2020-12-01) -
Cardiac toxicity of coxibs: mechanisms of development and their prevention
by: O O Yakovleva, et al.
Published: (2018-11-01) -
The peripheral and central mechanisms of transition of acute to chronic pain and the possible role of cyclooxygenase-2 inhibition in the prevention of pain syndrome chronization
by: O. S. Davydov
Published: (2016-07-01) -
Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study
by: Acer I-Hung Chen, et al.
Published: (2022-10-01)